127 related articles for article (PubMed ID: 11891611)
1. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Lung; 2001; 179(4):197-207. PubMed ID: 11891611
[TBL] [Abstract][Full Text] [Related]
2. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(2):103-11. PubMed ID: 12953149
[TBL] [Abstract][Full Text] [Related]
3. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer (stage IIIb or IV) with a higher T stage (> T2). Technetium-99m methoxyisobutylisonitrile chest single photon emission computed tomography and P-glycoprotein express ion.
Hsu WH; Yen RF; Kao CH; Shiun SC; Hsu NY; Lin CC; Lee CC
Oncology; 2002; 63(2):173-9. PubMed ID: 12239453
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Changlai SP; Lee JK
J Nucl Med; 2001 Jan; 42(1):17-20. PubMed ID: 11197970
[TBL] [Abstract][Full Text] [Related]
5. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression.
Yeh JJ; Hsu WH; Wang JJ; Ho ST; Kao A
Respiration; 2003; 70(1):32-5. PubMed ID: 12584388
[TBL] [Abstract][Full Text] [Related]
6. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
8. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
[TBL] [Abstract][Full Text] [Related]
9. To predict chemotherapy response using technetium-99m tetrofosmin and compare with p-glycoprotein and multidrug resistance related protein-1 expression in patients with untreated small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Lett; 2001 Aug; 169(2):181-8. PubMed ID: 11431107
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer.
Yeh JJ; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Tumour Biol; 2003; 24(3):151-5. PubMed ID: 14610319
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of chemotherapy response in patients with small cell lung cancer using Technetium-99m-tetrofosmin.
Kao CH; Ho YJ; Shen YY; Lee JK
Anticancer Res; 1999; 19(3B):2311-5. PubMed ID: 10472350
[TBL] [Abstract][Full Text] [Related]
12. Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression.
Liang JA; Shiau YC; Yang SN; Lin FJ; Lin CC; Kao A; Lee CC
Oncol Rep; 2002; 9(2):307-12. PubMed ID: 11836597
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between 99m Tc-tetrofosmin uptake and P-glycoprotein expression in non-small-cell lung cancer].
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
Rev Esp Med Nucl; 1998; 17(6):427-34. PubMed ID: 9873130
[TBL] [Abstract][Full Text] [Related]
15. The value of Tc-99m tetrofosmin scintimammography in the assessment of P-glycoprotein in patients with breast cancer.
Silov G; Erdoğan Z; Özdal A; Tutuş A; Tekin Y; Karaman H; Turhal Ö
Hell J Nucl Med; 2013; 16(3):218-22. PubMed ID: 24137583
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m methoxyisobutylisonitrile chest imaging for small-cell lung cancer. Relationship to chemotherapy response (six courses of combination of cisplatin and etoposide) and p-glycoprotein or multidrug resistance related protein expression.
Kao A; Shiun SC; Hsu NY; Sun SS; Lee CC; Lin CC
Ann Oncol; 2001 Nov; 12(11):1561-6. PubMed ID: 11822755
[TBL] [Abstract][Full Text] [Related]
17. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
Changlai SP; Tsai CS; Ding HJ; Huang WT; Kao A; Hsu WH
Med Oncol; 2003; 20(3):247-53. PubMed ID: 14514974
[TBL] [Abstract][Full Text] [Related]
18. Predicting chemotherapy response and comparing with P-glycoprotein expression using technetium-99m tetrofosmin scan in untreated malignant lymphomas.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Lett; 2001 Sep; 170(2):139-46. PubMed ID: 11463491
[TBL] [Abstract][Full Text] [Related]
19. Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer.
Chiou JF; Liang JA; Hsu WH; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(5):267-73. PubMed ID: 14705770
[TBL] [Abstract][Full Text] [Related]
20. Tetrofosmin as predictors of tumour response.
Fuster D; Viñolas N; Mallafré C; Pavia J; Martín F; Pons F
Q J Nucl Med; 2003 Mar; 47(1):58-62. PubMed ID: 12714956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
